SS&C TechnologiesSSNC
About: SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.
Employees: 26,000
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
1,183% more call options, than puts
Call options by funds: $61.2M | Put options by funds: $4.77M
27% more funds holding in top 10
Funds holding in top 10: 15 [Q3] → 19 (+4) [Q4]
2.18% more ownership
Funds ownership: 82.36% [Q3] → 84.53% (+2.18%) [Q4]
6% more repeat investments, than reductions
Existing positions increased: 237 | Existing positions reduced: 224
5% more capital invested
Capital invested by funds: $15B [Q3] → $15.7B (+$713M) [Q4]
3% less funds holding
Funds holding: 652 [Q3] → 630 (-22) [Q4]
11% less first-time investments, than exits
New positions opened: 78 | Existing positions closed: 88
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
DA Davidson Peter Heckmann 51% 1-year accuracy 24 / 47 met price target | 23%upside $102 | Buy Maintained | 10 Feb 2025 |
RBC Capital Daniel Perlin 44% 1-year accuracy 24 / 54 met price target | 16%upside $96 | Outperform Maintained | 7 Feb 2025 |
Raymond James Patrick O'Shaughnessy 67% 1-year accuracy 12 / 18 met price target | 14%upside $95 | Strong Buy Maintained | 7 Feb 2025 |
UBS Kevin Mcveigh 29% 1-year accuracy 4 / 14 met price target | 27%upside $105 | Buy Maintained | 7 Feb 2025 |
Needham Mayank Tandon 42% 1-year accuracy 48 / 113 met price target | 27%upside $105 | Buy Maintained | 7 Feb 2025 |
Financial journalist opinion
Based on 10 articles about SSNC published over the past 30 days









